IMNM
ImmunomeCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
IMNM vs peer average
54/100
IMNM vs. peer average (C vs. C)
Grade spread
B 2 · C 4 · D 2 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
CLDX is the first available peer comparator.
Celldex is the closest candidate in the provided set for a development-stage biotech valuation comparison: event-driven, cash-burn funded and reliant on clinical execution, though it is not a direct desmoid or ADC peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMNM
Immunome
CLDX
Celldex Therapeutics
Grade
C
C
Momentum
84
73
Value
41
41
Sentiment
39
44
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs CLDX
IMNM / CLDX
Grade Position
In line
IMNM vs. peer average (C vs. C)
54/100
Momentum
84
IMNMValue
41
IMNMSentiment
39
CLDXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMNM
CLDX is the first peer returned for this comparison set.